Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chikuma Hamada

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Pharmaceutical Statistics|September 11, 2013
A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trialsTakashi Asakawa, Chikuma Hamada
Statistics in Medicine|May 26, 2016
An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trialsHiroyuki Sato, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|January 19, 2012
Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experimentsAkihiro Hirakawa, Chikuma Hamada, Isao Yoshimura
Pharmaceutical Statistics|July 22, 2014
Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer dataJunichi Asano, Akihiro Hirakawa, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 15, 2014
Validity and effectiveness of the Williams multiple comparison test in pharmacological studiesNobuhiro Nakanishi, Toshio Hashimoto, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 15, 2010
[Evaluation of a partial agonist by a logistic model with relative efficacy.]Masayuki Yamada, Naoto Niki, Chikuma Hamada
Statistics in Medicine|May 8, 2013
A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trialsAkihiro Hirakawa, Chikuma Hamada, Shigeyuki Matsui
Journal of Biopharmaceutical Statistics|November 6, 2014
A Dose-Finding Method Based on Multiple Dosing in Two-Agent Combination Phase I TrialsYasuyuki Kakurai, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|September 9, 2017
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design frameworkShogo Nomura, Akihiro Hirakawa, Chikuma Hamada
Cancer Informatics|March 24, 2012
Gene Selection using a High-Dimensional Regression Model with Microarrays in Cancer Prognostic StudiesShuhei Kaneko, Akihiro Hirakawa, Chikuma Hamada
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Pharmaceutical Statistics|September 11, 2013
A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trialsTakashi Asakawa, Chikuma Hamada
Statistics in Medicine|May 26, 2016
An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trialsHiroyuki Sato, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|January 19, 2012
Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experimentsAkihiro Hirakawa, Chikuma Hamada, Isao Yoshimura
Pharmaceutical Statistics|July 22, 2014
Assessing the prediction accuracy of cure in the Cox proportional hazards cure model: an application to breast cancer dataJunichi Asano, Akihiro Hirakawa, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 15, 2014
Validity and effectiveness of the Williams multiple comparison test in pharmacological studiesNobuhiro Nakanishi, Toshio Hashimoto, Chikuma Hamada
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 15, 2010
[Evaluation of a partial agonist by a logistic model with relative efficacy.]Masayuki Yamada, Naoto Niki, Chikuma Hamada
Statistics in Medicine|May 8, 2013
A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trialsAkihiro Hirakawa, Chikuma Hamada, Shigeyuki Matsui
Journal of Biopharmaceutical Statistics|November 6, 2014
A Dose-Finding Method Based on Multiple Dosing in Two-Agent Combination Phase I TrialsYasuyuki Kakurai, Akihiro Hirakawa, Chikuma Hamada
Journal of Biopharmaceutical Statistics|September 9, 2017
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design frameworkShogo Nomura, Akihiro Hirakawa, Chikuma Hamada
Cancer Informatics|March 24, 2012
Gene Selection using a High-Dimensional Regression Model with Microarrays in Cancer Prognostic StudiesShuhei Kaneko, Akihiro Hirakawa, Chikuma Hamada
Pageof 10